We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXTR icon
751
Extreme Networks
EXTR
$3.15B
$293K 0.05%
42,506
-49,154
-54% -$264K
NOVA
752
DELISTED
Sunnova Energy
NOVA
$293K 0.05%
6,500
-30,445
-82% -$1.06M
SKT icon
753
Tanger
SKT
$4.52B
$293K 0.05%
29,386
+13,089
+80% +$111K
SFL icon
754
SFL Corp
SFL
$1.61B
$292K 0.05%
+46,473
New +$322K
CTT
755
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$292K 0.05%
31,161
+7,546
+32% +$68.7K
ASIX icon
756
AdvanSix
ASIX
$444M
$290K 0.05%
+14,518
New +$249K
XLY icon
757
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$289K 0.05%
+3,598
New +$277K
AZTA icon
758
Azenta
AZTA
$1.48B
$288K 0.05%
4,239
-1,835
-30% -$114K
THC icon
759
Tenet Healthcare
THC
$21.1B
$288K 0.05%
+7,211
New +$233K
CLDR
760
DELISTED
Cloudera, Inc.
CLDR
$288K 0.05%
20,697
+5,539
+37% +$63.5K
ETNB
761
DELISTED
89bio
ETNB
$287K 0.05%
+11,774
New +$301K
REVG
762
DELISTED
REV Group
REVG
$287K 0.05%
+32,587
New +$290K
UAA icon
763
Under Armour
UAA
$2.6B
$287K 0.05%
+16,700
New +$255K
ZGNX
764
DELISTED
Zogenix, Inc.
ZGNX
$287K 0.05%
14,362
-2,423
-14% -$49.5K
HAL icon
765
Halliburton
HAL
$26.6B
$286K 0.05%
15,155
-93,161
-86% -$1.45M
SAVE
766
DELISTED
Spirit Airlines, Inc.
SAVE
$286K 0.05%
+11,713
New +$243K
ALLO icon
767
Allogene Therapeutics
ALLO
$694M
$285K 0.05%
+11,273
New +$367K
MASI
768
DELISTED
Masimo
MASI
$284K 0.05%
+1,059
New +$264K
MKTX icon
769
MarketAxess Holdings
MKTX
$5.72B
$284K 0.05%
498
-15
-3% -$8.17K
RITM icon
770
Rithm Capital
RITM
$5.69B
$284K 0.05%
28,585
-30,601
-52% -$271K
TIGO icon
771
Millicom
TIGO
$16.3B
$284K 0.05%
7,311
-251
-3% -$8.84K
NAGE
772
Niagen Bioscience
NAGE
$247M
$284K 0.05%
59,221
-3,547
-6% -$17.3K
CFG icon
773
Citizens Financial Group
CFG
$30.6B
$283K 0.05%
7,900
-11,682
-60% -$367K
ARCT icon
774
Arcturus Therapeutics
ARCT
$211M
$282K 0.05%
+6,511
New +$441K
HVT icon
775
Haverty Furniture Companies
HVT
$454M
$282K 0.05%
10,202
-46,081
-82% -$1.22M

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.